The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Multiple sclerosis (MS) is the most common neurological disease of young adults, with very high costs in loss of quality of life, reduced contribution of sufferers to the workplace, and in treatment. No cures exist and its cause is unknown. It is, however, known to be a largely genetic disease - but the genes associated with it have yet to be identified. An international consortium, known as GAMES (Genes Associated with Multiple Sclerosis) has now completed a screen of all human chromosomes usin ....Multiple sclerosis (MS) is the most common neurological disease of young adults, with very high costs in loss of quality of life, reduced contribution of sufferers to the workplace, and in treatment. No cures exist and its cause is unknown. It is, however, known to be a largely genetic disease - but the genes associated with it have yet to be identified. An international consortium, known as GAMES (Genes Associated with Multiple Sclerosis) has now completed a screen of all human chromosomes using 6000 markers to identify regions with genetic differences in multiple sclerosis patients. The Australian contribution to this study was funded by the NHMRC. This project is a continuation of the first, only moving on to fine-scale mapping of the regions identified in GAMES1, so that single genes, rather than genetic regions, are the focus for the study. It also aims to ensure Australian participation as an equal player in phase II of this major international collaboration. The Australian results will contribute to the overall study. If associations identified in single countries are found in other countries, this confirms the validity of the association. In addition, genes which are only slightly associated with disease in individual countries, may become more meaningful if they are found to be associated in the studies from other countries. In this way a sensitive and robust comparison of the genes which affect predisposition to MS will be identified and this information can be used to target molecular pathways for drug intervention.Read moreRead less
Clinical Implications Of IL7R Genotype: From Disease Risk To Disease Management
Funder
National Health and Medical Research Council
Funding Amount
$627,765.00
Summary
We’ve identified a genetic test (IL7R?) that may predict and prevent the risk of patients (i) failing to respond adequately to treatment for HIV (ii) who are at high risk of death after bone marrow transplantation and (iii) who fail to respond to interferon treatment for MS. This project aims to confirm these in very large patient groups and uncover the cellular basis for the genetic effect. Our goal is to provide a novel test that will improve patient outcomes in 3 serious disease states.